Cellular Ratios in the Approach and Prognosis of Breast Cancer: an integrated literature review
DOI:
https://doi.org/10.33448/rsd-v10i14.21862Keywords:
Breast cancer; Cellular ratios; Prognosis; Inflammatory biomarkers; Survival.Abstract
Breast cancer is currently the cancer that most affects women worldwide, and taking into account that the appearance of this pathology is the sum of several factors such as genetic predisposition, it becomes complex the elaboration of disease prognoses. Thus, it is necessary to seek means based on scientific research that can help in this context. This study aimed to discuss the existing conformity between cellular relations and their meanings in breast cancer. For this, an integrative literature review was carried out in the PubMed database of the productions from the last 10 years. The descriptors used were: "neutrophil lymphocyte ratio", "monocyte lymphocyte ratio", "breast cancer" and "prognosis", which were combined to delimit the search. Six articles were selected at the end of the search steps. Being the years 2018 and 2020 the most prevalent with 33.3% of publications each, followed by the year 2019 and 2021 with 16.6% of publications each. Regarding the country of origin of the studies, 2 articles were conducted in Poland (33.3%), and in each of these countries, being China, Spain, Belgium, and the Republic of Korea, one article was published respectively (16.6%). Evidence showed that patients with higher NLR obtained shorter survival time, on the other hand, patients with higher values of LMR had better prognosis than the other relations. Therefore, it is worth emphasizing the importance of cellular ratios to be investigated in patients with breast cancer in order to optimize the prognosis and, consequently, to seek the best therapeutic methods to raise the survival time of neoplastics.
References
Abdalla, D. R., Simoens, C., Bogers, J. P., Murta, E. F. & Michelin, M. A. (2015). Angiogenesis Markers in Gynecological Tumors and Patents for Anti-Angiogenic Approach: Review. Recent Pat Anticancer Drug Discov. 2015,10(3):298-307.
Araújo, B. R. A., Coelho, C. A. D., Santos, J. O., Oliveira, M. de, Queiroz, R. de C. M., & Abdalla, D. R. (2021). Papel da relação neutrófilo-linfócito no valor prognóstico para exacerbação e mortalidade entre indivíduos com Doença Pulmonar Obstrutiva Crônica: revisão integrativa da literatura. Research, Society and Development, 10(12), e86101220080.
Azambuja, E. (2007). Marcadores prognósticos e preditivos e sua importância na individualização do tratamento de pacientes com câncer de mama [Tese de Doutorado]. Universidade Federal Do Rio Grande do Sul.
Batschauer, A. P. B., Fernandes, A. P. S. M. & Carvalho, M. G. (2009). Avaliação hemostática e molecular em mulheres com câncer de mama receptor hormonal negativo. [Tese de Doutorado]: Universidade Federal de Minas Gerais.
Bianco, T. M., Abdalla, D. R., Desidério, C. S., et al. (20017). The influence of physical activity in the anti-tumor immune response in experimental breast tumor. Immunol Lett. 2017 Oct,190:148-158.
Botelho, L. L. R., Cunha, C. C. A. & Macedo, M. (2011). The integrative review method in organizational studies. Gestão e sociedade. 5(11): 121-136.
Brasil. (2020). Ministério da Saúde. Instituto Nacional de Câncer. Estimativa: Incidência de câncer no Brasil. INCA, 2020.
Cho, U., et al. (2018). Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer. Plos One. 13(7): e0200936.
Diana, C. A. F., et al. (2004). Factores pronósticos del cáncer de mama: modelo predictivo. Rev Oncol. 6(8):472-482.
Faria, E. H., Kim, D., Sisconetto, R. M., et al. (2021). Analysis of Knowledge About Male Breast Cancer Among Higher Education Male Students. Eur J Breast Health. 17(4):333-340.
Godinho, E. R. & Koch, H. A. (2004). Breast cancer screening: physicians related issues. Radiol Bras. 37(2): 91-99.
Guerra, M. R. (2007). Sobrevida e fatores prognósticos para o câncer de mama em Juiz de Fora, Minas Gerais, na coorte diagnosticada entre 1998 e 2000. 2007. [Tese de Doutorado]. Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rio de Janeiro.
Huszno, J. & Kolosza, Z. (2019). Prognostic value of the neutrophil lymphocyte, platelet lymphocyte and monocyte lymphocyte ratio in breast cancer patients. Oncol Lett. (6):6275-6283.
Huszno, J., et al. (2020). Prognostic Value of the Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios in Male Breast Cancer Patients. Oncology. 98(7): 487-492.
Inumaru L., Silveira, E. A. & Naves, M. M. V. (2011). Fatores de risco e de proteção para câncer de mama: uma revisão sistemática. Cadernos de Saúde Pública. 27(7): 1249-1270.
Losada B., et al. (2019) Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients. Clin Transl Oncol. 21(7):855-863.
Luchs, A. & Pantaleão, C. (2010). Apoptose e modelos in vivo para estudo das moléculas relacionadas a este fenômeno. Einstein. 8(4): 495-497.
Ma, Y., Zhang, J. & Chen, X., et al (2021). Lymphocyte-to-Monocyte Ratio is Associated with the Poor Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Cancer Manag Res. 13:1571-1580.
Nastri, C. O., Martins, W. P. & Lenharte, R. J. (2011). Ultrasonography in breast cancer screening. Revista Femina. 39(2): 97-102.
Ribeiro-Silva, A. (2012). Core biopsy: uma técnica confiável para o diagnóstico histopatológico do câncer de mama? J Bras Patol Med Lab. 48(1): 8-9.
Salimena, A. M. O., Campos, T. S., Melo, M. C. S. C. & Magacho, E. J. C. (2012). Mulheres Enfrentando O Câncer De Mama. remE – Rev. Min. Enferm.,16(3): 339-347.
Souza, M. T., Silva, M. D., & Carvalho, R. (2010). Revisão integrativa: o que é e como fazer. Einstein, 8(1): 102-106.
Van Berckelaer C., et al. (2020). A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer. The Breast. 53: 212-220.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Caio André de Oliveira Alcântara; Camilla Vitória Querino do Carmo; Gabriel Guimarães Cunha Silva; Karol Stheffani Mollinedo Pereira; Yasmin Nogueira de Sousa; Douglas Reis Abdalla
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
